… smokers with mild airways obstruction. Use of an inhaled anticholinergic bronchodilator results
… Use of the bronchodilator did not influence the long-term decline of FEV 1 .(JAMA. 1994;…

… In summary, we have found that a cohort of volunteers with mild-to-moderate COPD who
enrolled in a clinical trial of smoking cessation and inhaled anticholinergic bronchodilator …

… Tiotropium is a newly developed, once-daily inhaled anticholinergic bronchodilator. Because
… Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on …

… used to record the following properties of each study: the dose and frequency of the inhaled
anticholinergic and control interventions, … long-acting bronchodilator, such as the inhaled β-…

… ipratropium bromide (Atrovent), smoking intervention and an inhaled placebo identical in …
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on …

… Reduction in risk factors is essential. For patients who still smoke, smoking cessation is
the most important (and cost-effective) modality, and education plays an important role in …

… Inhaled bronchodilators are also generally preferred over … plus ipratropium group compared
to the smoking cessation … , a dose-effect relationship between ipratropium use and SVT …

… produce these unwanted systemic effects depends on the … ammonium-inhaled anticholinergic
bronchodilators over older tertiary … 5-year Lung Health Study, an early intervention study in …

… The long-term effects of currently used bronchodilators are not well known, and long-term …
Two anticholinergic bronchodilators are currently available in the United States for clinical …

… have additional bronchodilator activity analogous to the use of these agents in … Types of
interventions … In the absence of even short term data on the effects of anticholinergic agents on …